Evidence
- ashina-m_2021_rct_reduction-in-the-severity-and-duration-of-headache-following-fremanezumab-treatment-in-patients-with-episodic-and-chronic-migraine
- ashina-m_2021_rct_reduction-in-the-severity-and-duration-of-headache-following-fremanezumab-treatment-in-patients-with-episodic-and-chronic-migraine
- ashina-m_2021_rct_reduction-in-the-severity-and-duration-of-headache-following-fremanezumab-treatment-in-patients-with-episodic-and-chronic-migraine